Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuraxis Q3 EPS $(1.35) Down From $(1.14) YoY, Sales $477.46K Down From $618.80K YoY

Author: Benzinga Newsdesk | November 20, 2023 06:46pm

Neuraxis (AMEX:NRXS) reported quarterly losses of $(1.35) per share. This is a 18.42 percent decrease over losses of $(1.14) per share from the same period last year. The company reported $477.46 thousand in sales this quarter. This is a 22.84 percent decrease over sales of $618.80 thousand the same period last year.

Posted In: NRXS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist